(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 5.93% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.82%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.12%.
Albemarle's revenue in 2026 is $5,494,583,000.On average, 26 Wall Street analysts forecast ALB's revenue for 2026 to be $688,266,623,236, with the lowest ALB revenue forecast at $542,617,329,251, and the highest ALB revenue forecast at $833,680,047,919. On average, 24 Wall Street analysts forecast ALB's revenue for 2027 to be $729,543,751,086, with the lowest ALB revenue forecast at $612,552,577,294, and the highest ALB revenue forecast at $972,725,001,448.
In 2028, ALB is forecast to generate $770,113,271,030 in revenue, with the lowest revenue forecast at $614,557,466,361 and the highest revenue forecast at $984,636,401,199.